U.S. FDA Inspection Finds Numerous Concerns At Wockhardt Chikalthana Plant – Report
This article was originally published in PharmAsia News
Executive Summary
A U.S. FDA inspection of Wockhardt Ltd.’s Chikalthana plant about 200 miles east of the financial hub of Mumbai came up with numerous concerns about quality control at the factory that produces a generic version of Toprol-XL (metoprolol succinate), according to a report by Bloomberg News.